| Symbol |
Name |
Standardized Value |
|
GAST
|
gastrin
|
3.976
|
|
MEN1
|
multiple endocrine neoplasia I
|
3.75
|
|
SCT
|
secretin
|
3.432
|
|
SST
|
somatostatin
|
3.337
|
|
PPY
|
pancreatic polypeptide
|
3.084
|
|
CHGA
|
chromogranin A
|
3.084
|
|
VIP
|
vasoactive intestinal peptide
|
2.976
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
2.921
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
2.914
|
|
GCG
|
glucagon
|
2.74
|
|
SSTR2
|
somatostatin receptor 2
|
2.566
|
|
SYP
|
synaptophysin
|
2.533
|
|
POMC
|
proopiomelanocortin
|
2.477
|
|
SSTR5
|
somatostatin receptor 5
|
2.413
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.383
|
|
INS
|
insulin
|
2.366
|
|
DAXX
|
death-domain associated protein
|
2.348
|
|
PRL
|
prolactin
|
2.279
|
|
PTH
|
parathyroid hormone
|
2.263
|
|
HRH2
|
histamine receptor H2
|
2.26
|
|
SSTR1
|
somatostatin receptor 1
|
2.235
|
|
NTS
|
neurotensin
|
2.192
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
2.144
|
|
GHRH
|
growth hormone releasing hormone
|
2.142
|
|
JUND
|
jun D proto-oncogene
|
2.118
|
|
NF1
|
neurofibromin 1
|
2.1
|
|
GRP
|
gastrin-releasing peptide
|
2.077
|
|
CCKBR
|
cholecystokinin B receptor
|
2.071
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
2.061
|
|
SSTR4
|
somatostatin receptor 4
|
1.963
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.936
|
|
SSTR3
|
somatostatin receptor 3
|
1.904
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.838
|
|
MLN
|
motilin
|
1.806
|
|
TSC2
|
tuberous sclerosis 2
|
1.8
|
|
GRPR
|
gastrin-releasing peptide receptor
|
1.751
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
1.745
|
|
CHGB
|
chromogranin B
|
1.744
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
1.744
|
|
CDC73
|
cell division cycle 73
|
1.743
|
|
RET
|
ret proto-oncogene
|
1.725
|
|
CCK
|
cholecystokinin
|
1.722
|
|
SCTR
|
secretin receptor
|
1.714
|
|
FOXN3
|
forkhead box N3
|
1.707
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.678
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
1.63
|
|
CASR
|
calcium-sensing receptor
|
1.62
|
|
CRH
|
corticotropin releasing hormone
|
1.619
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
1.602
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.591
|
|
CDX2
|
caudal type homeobox 2
|
1.542
|
|
TP53
|
tumor protein p53
|
1.541
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.516
|
|
MUTYH
|
mutY homolog
|
1.509
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.503
|
|
NMBR
|
neuromedin B receptor
|
1.496
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.471
|
|
BRS3
|
bombesin-like receptor 3
|
1.464
|
|
TAC1
|
tachykinin, precursor 1
|
1.456
|
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
1.443
|
|
NMB
|
neuromedin B
|
1.441
|
|
SMAD4
|
SMAD family member 4
|
1.429
|
|
IFNA1
|
interferon, alpha 1
|
1.418
|
|
ISL1
|
ISL LIM homeobox 1
|
1.417
|
|
IFNA2
|
interferon, alpha 2
|
1.405
|
|
IGF2
|
insulin-like growth factor 2
|
1.404
|
|
SSR2
|
signal sequence receptor, beta (translocon-associated protein beta)
|
1.396
|
|
IFNA16
|
interferon, alpha 16
|
1.395
|
|
IFNA7
|
interferon, alpha 7
|
1.395
|
|
IFNA10
|
interferon, alpha 10
|
1.394
|
|
IFNA8
|
interferon, alpha 8
|
1.394
|
|
IFNA21
|
interferon, alpha 21
|
1.394
|
|
IFNA14
|
interferon, alpha 14
|
1.394
|
|
IFNA6
|
interferon, alpha 6
|
1.393
|
|
IFNA5
|
interferon, alpha 5
|
1.392
|
|
IFNA13
|
interferon, alpha 13
|
1.391
|
|
IFNA4
|
interferon, alpha 4
|
1.389
|
|
IFNA17
|
interferon, alpha 17
|
1.376
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
1.373
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.372
|
|
TSC1
|
tuberous sclerosis 1
|
1.365
|
|
NKX6-3
|
NK6 homeobox 3
|
1.36
|
|
SNED1
|
sushi, nidogen and EGF-like domains 1
|
1.36
|
|
DEPDC5
|
DEP domain containing 5
|
1.349
|
|
HDC
|
histidine decarboxylase
|
1.345
|
|
INSM1
|
insulinoma-associated 1
|
1.339
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.336
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.331
|
|
CCKAR
|
cholecystokinin A receptor
|
1.33
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
1.328
|
|
PTEN
|
phosphatase and tensin homolog
|
1.321
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.318
|
|
AP2S1
|
adaptor-related protein complex 2, sigma 1 subunit
|
1.298
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.282
|
|
GNAS
|
GNAS complex locus
|
1.282
|
|
NEUROG3
|
neurogenin 3
|
1.279
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
1.269
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
1.269
|
|
GAS1
|
growth arrest-specific 1
|
1.268
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
1.255
|
|
ALB
|
albumin
|
1.244
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.241
|
|
CORT
|
cortistatin
|
1.234
|
|
GCGR
|
glucagon receptor
|
1.206
|
|
PRMT5
|
protein arginine methyltransferase 5
|
1.194
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.192
|
|
EGF
|
epidermal growth factor
|
1.186
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
1.179
|
|
GIP
|
gastric inhibitory polypeptide
|
1.17
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.167
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.161
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.159
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.158
|
|
GPR101
|
G protein-coupled receptor 101
|
1.157
|
|
GCM2
|
glial cells missing homolog 2 (Drosophila)
|
1.153
|
|
IPMK
|
inositol polyphosphate multikinase
|
1.145
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.144
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.142
|
|
CCDC116
|
coiled-coil domain containing 116
|
1.142
|
|
REN
|
renin
|
1.127
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
1.124
|
|
SYPL1
|
synaptophysin-like 1
|
1.111
|
|
GH1
|
growth hormone 1
|
1.11
|
|
MEA1
|
male-enhanced antigen 1
|
1.109
|
|
BRCA2
|
breast cancer 2, early onset
|
1.103
|
|
RBBP5
|
retinoblastoma binding protein 5
|
1.102
|
|
PAX8
|
paired box 8
|
1.101
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
1.1
|
|
IAPP
|
islet amyloid polypeptide
|
1.094
|
|
SETD2
|
SET domain containing 2
|
1.078
|
|
MLH1
|
mutL homolog 1
|
1.074
|
|
EGFR
|
epidermal growth factor receptor
|
1.066
|
|
KRT7
|
keratin 7, type II
|
1.064
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.061
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
1.055
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
1.055
|
|
GH2
|
growth hormone 2
|
1.043
|
|
SYPL2
|
synaptophysin-like 2
|
1.038
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
1.038
|
|
NEUROD1
|
neuronal differentiation 1
|
1.037
|
|
CHEK2
|
checkpoint kinase 2
|
1.036
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.027
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
1.024
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.022
|
|
TKFC
|
triokinase/FMN cyclase
|
1.021
|
|
TGM2
|
transglutaminase 2
|
1.015
|
|
COPA
|
coatomer protein complex, subunit alpha
|
1.006
|
|
KRT19
|
keratin 19, type I
|
1.003
|
